Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2529750015 | Imatinib (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
2533184011 | Imatinib | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Imatinib (substance) | Is a | Pyridine and/or pyridine derivative | true | Inferred relationship | Some | ||
Imatinib (substance) | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
Imatinib (substance) | Is a | Substance categorized by disposition | true | Inferred relationship | Some | ||
Imatinib (substance) | Has disposition (attribute) | Disposition | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Imatinib only product | Has active ingredient | True | Imatinib (substance) | Inferred relationship | Some | 1 |
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Imatinib (substance) | Inferred relationship | Some | 1 |
Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Imatinib (substance) | Inferred relationship | Some | 1 |
Reference Sets